The current valuation score of Regenxbio Inc is 7.69, ranking 211 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.41, which is -28.48% below the recent high of -1.01 and -227.03% above the recent low of -4.62.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.